Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
- 19 March 1992
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 356 (6366) , 215-221
- https://doi.org/10.1038/356215a0
Abstract
Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumori-genesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.Keywords
This publication has 47 references indexed in Scilit:
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genesNature, 1988
- Mortality, Major Cause of Moribundity, and Spontaneous Tumors in CD-1 MiceToxicologic Pathology, 1988
- p53 and DNA polymerase α compete for binding to SV40 T antigenNature, 1987
- Mouse p53 inhibits SV40 origin-dependent DNA replicationNature, 1987
- Participation of p53 cellular tumour antigen in transformation of normal embryonic cellsNature, 1984
- A monoclonal antibody that recognizes B cells and B cell precursors in mice.The Journal of Experimental Medicine, 1981
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979